Lower Dose Decitabine (DAC)-Primed TC (Carboplatin-Paclitaxel) Regimen in Ovary Cancer

Clinical trial NCT02159820 · UNKNOWN

Trial details

NCT number: NCT02159820
Sponsor: Chinese PLA General Hospital
Status: UNKNOWN
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Primary Malignant Neoplasm of Ovary FIGO Stages II to IV

Start date: 2014-06-01
Primary completion: 2024-06-01
Enrollment: 500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.